drugset / Trial / NCT01850277
Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this prospective randomized study is to determine whether patients on cardiac resynchronization therapy with concomitant long-standing persistent or permanent atrial fibrillation would benefit from a strategy to restore and maintain sinus rhythm (rhythm control strategy) in comparison to a rate control strategy in terms of higher biventricular paced beats percentage.
Timeline
- Start
- 2013-10
- Primary completion
- 2016-12
- Completion
- 2017-03
Publications
- Ciszewski JB, Tajstra M, Kowalik I, Maciag A, Chwyczko T, Jankowska A, Smolis-Bak E, Firek B, Zajac D, Karwowski J, Szwed H, Pytkowski M, Gasior M, Sterlinski M. Rhythm and rate control strategies in patients with long-standing persistent atrial fibrillation treated with cardiac resynchronization: the results of the randomized Pilot-CRAfT study. Clin Res Cardiol. 2026 Apr;115(4):566-575. doi: 10.1007/s00392-024-02541-z. Epub 2024 Oct 10.
- Ciszewski J, Maciag A, Kowalik I, Syska P, Lewandowski M, Farkowski MM, Borowiec A, Chwyczko T, Pytkowski M, Szwed H, Sterlinski M. Comparison of the rhythm control treatment strategy versus the rate control strategy in patients with permanent or long-standing persistent atrial fibrillation and heart failure treated with cardiac resynchronization therapy - a pilot study of Cardiac Resynchronization in Atrial Fibrillation Trial (Pilot-CRAfT): study protocol for a randomized controlled trial. Trials. 2014 Oct 4;15:386. doi: 10.1186/1745-6215-15-386.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amiodarone | Small molecule | 200 mg | Oral |